Dana-Farber Cancer Institute: Brain Neoplasms trials
The registry lists 13 Brain Neoplasms studies with Dana-Farber Cancer Institute as lead sponsor. 3 are open to participants now and 4 have results posted.
Phase 1 6Phase 2 3No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Listen Aphasia Pilot StudyNot yet recruitingNCT07732140Not applicable
- Neurocognitive Assessment CNSL and LGGNot yet recruitingNCT07710131Not applicable
- Stereotactic Magnetic Resonance Guided Radiation TherapyRecruitingNCT04115254Not applicable
- A Study of Abemaciclib in Recurrent GlioblastomaActive, not recruitingNCT02981940Phase 2Results posted
- A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive GlioblastomaActive, not recruitingNCT02852655Phase 1Results posted
- Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain MetastasesCompletedNCT02260531Phase 2Results posted
- Carboplatin and Bevacizumab for Progressive Breast Cancer Brain MetastasesCompletedNCT01004172Phase 2Results posted
- Phase I Study of Marizomib + Panobinostat for Children With DIPGTerminatedNCT04341311Phase 1
- Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric CancerCompletedNCT03654716Phase 1
- A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2Active, not recruitingNCT03152318Phase 1
- Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or LymphomaCompletedNCT02909777Phase 1
- ARRY-380 + Trastuzuamab for Breast w/ Brain MetsCompletedNCT01921335Phase 1
- A-protein Levels in Adult and Pediatric Brain Tumor PatientsCompletedNCT00165542